Business CircleBusiness Circle
  • Home
  • AI News
  • Startups
  • Markets
  • Finances
  • Technology
  • More
    • Human Resource
    • Marketing & Sales
    • SMEs
    • Lifestyle
    • Trading & Stock Market
What's Hot

Stop Waiting for Rates to Drop—New Construction Investors Already Bought at 4%

June 18, 2026

Novellia Raises $18M to Fix the $50B Data Problem Sitting at the Heart of Drug Development – AlleyWatch

June 18, 2026

265. “We spend 179% of what we make. Are we screwed?”

June 18, 2026
Facebook Twitter Instagram
Thursday, June 18
  • Advertise with us
  • Submit Articles
  • About us
  • Contact us
Business CircleBusiness Circle
  • Home
  • AI News
  • Startups
  • Markets
  • Finances
  • Technology
  • More
    • Human Resource
    • Marketing & Sales
    • SMEs
    • Lifestyle
    • Trading & Stock Market
Subscribe
Business CircleBusiness Circle
Home » Novellia Raises $18M to Fix the $50B Data Problem Sitting at the Heart of Drug Development – AlleyWatch
Startups

Novellia Raises $18M to Fix the $50B Data Problem Sitting at the Heart of Drug Development – AlleyWatch

Business Circle TeamBy Business Circle TeamJune 18, 2026No Comments11 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Novellia Raises M to Fix the B Data Problem Sitting at the Heart of Drug Development – AlleyWatch
Share
Facebook Twitter LinkedIn Pinterest Email


actual world, however the infrastructure constructed to ship that understanding has a elementary flaw at its heart: sufferers don’t have any seat on the desk. The business spends greater than $50B yearly on real-world knowledge ecosystems dominated by claims brokers and hospital document aggregators that sew collectively incomplete, fragmented datasets whereas leaving out the individuals these datasets are alleged to signify. In the meantime, sufferers with critical and sophisticated circumstances spend hours monitoring down their very own information throughout dozens of disconnected techniques, carrying binders from specialist to specialist simply to provide every new supplier a coherent image of their historical past. Novellia assaults each issues concurrently, giving sufferers a free software to unify as much as 20 years of well being knowledge from greater than 50,000 healthcare techniques in seconds, then, solely with express consent, making that de-identified, anonymized knowledge out there to biopharma researchers as a longitudinal, constantly up to date dataset that claims knowledge and single-system EHR information merely can’t match. The platform’s proprietary NLP fashions extract alerts from unstructured scientific textual content, together with doctor notes, lab narratives, and diagnostic reviews, turning the richest and most missed layer of the medical document into research-ready intelligence. Already serving a number of of the highest 10 pharmaceutical firms on seven-figure, multi-year contracts, and acknowledged by MedTech Breakthrough and Fierce Outsourcing for its affect on drug improvement, Novellia has now closed new funding to scale the platform and broaden its affected person group.

AlleyWatch sat down with Novellia Cofounder and CEO Shashi Shankar to study extra in regards to the enterprise, its future plans, and the current $18M funding spherical that brings the corporate’s complete funding to $28M.

Who had been your traders and the way a lot did you increase?

We raised an $18 million Sequence A led by Spark Capital with participation from Khosla Ventures, Acrew Capital, Bling Capital, and TMV, bringing our complete funding to $28 million.

Inform us in regards to the services or products that Novellia gives.

Novellia provides individuals residing with critical and sophisticated medical circumstances a single place to search out and unify their full medical historical past, labs, imaging, scientific information, throughout each supplier they’ve ever seen. Most sufferers don’t have any actual thought the place their important well being knowledge lives or how one can get their arms on it. We repair that, free of charge.

And solely with affected person consent, Novellia companions with the world’s main biopharma firms to make use of de-identified, anonymized knowledge for important analysis. That’s how we assist individuals contribute to the invention of recent medicines, with out asking something of them past a sure.

What impressed the beginning of Novellia?

To be sincere, I by no means truly wished to start out an organization. However my grandfather was identified with most cancers, and I watched my mom grow to be his main caregiver. Within the months he had left, my mother coordinated his care throughout labs, imaging facilities, hospitals, and specialists. She carried binders of information from appointment to appointment, simply attempting to ensure each physician had an entire image of who he was and what his physique had been by means of.

On the identical time, I used to be working at Genentech, seeing firsthand how exhausting it was to entry high-quality, longitudinal well being knowledge for analysis. The identical elementary downside from two utterly completely different angles: important well being data was fragmented and almost inconceivable to entry on the moments it mattered most.

Novellia was constructed to resolve that. One place for sufferers to entry and handle their full well being historical past, freed from cost. A basis for higher analysis, higher care, and finally higher outcomes.

What market does Novellia goal and the way massive is it?

Novellia supplies knowledge options for the pharmaceutical business, which has a complete addressable market of almost $2 trillion.

What’s what you are promoting mannequin?

Our greatest-in-class affected person product is free, and it stays free. With express and clear affected person consent, we safely harness de-identified, anonymized, and combination datasets for analysis functions. We by no means share personally identifiable well being data. Novellia companions with researchers on real-world proof throughout oncology, uncommon illness, cardiometabolic circumstances, and different therapeutic areas. The business enterprise runs on that analysis facet: partnerships with medical affairs and scientific groups finding out what occurs to the sufferers they serve in the true world.

How are you making ready for a possible financial slowdown?

Life sciences, and significantly scientific improvement and medical affairs, has traditionally held up by means of financial cycles higher than most industries. When budgets tighten and scrutiny on healthcare spending will increase, demand for rigorous real-world proof tends to extend with it. That dynamic works in our favor.

We additionally run a disciplined operation. Capital is being deployed intentionally: scaling the platform, deepening our life sciences buyer relationships, and persevering with to develop the affected person group. Affected person engagement has confirmed largely unbiased of macroeconomic circumstances. Individuals’s well being wants don’t observe an financial calendar.

What was the funding course of like?

Humbling, in one of the best sense. You sit throughout from a few of the sharpest traders on the earth and rapidly study which elements of your thesis you possibly can defend fluently and which elements want extra work. The method forces a sort of readability that nothing else produces.

The conversations that went deepest had been with traders who had performed actual homework on the healthcare knowledge structure downside. As soon as somebody understood the dimensions of fragmentation in well being information, the dialog shifted from training to technique.

These had been the companions we had been in search of.

Discovering Spark Capital, Khosla, Acrew, Bling, and TMV took time. These corporations understood from the beginning that Novellia’s business mannequin and its affected person mission reinforce one another. That alignment formed each dialog as soon as time period sheets had been on the desk.

What are the most important challenges that you simply confronted whereas elevating capital?

The largest problem was the class itself. Actual-world knowledge has massive, established gamers with deep enterprise entrenchment, and any investor conversant in the area would moderately wish to perceive what makes your strategy really distinct.

The toughest factor to convey was the flywheel. Novellia’s solely supply of knowledge is sufferers themselves. We constructed a product sufferers truly wish to use and sufferers who select to take part authorize well being data that’s longitudinal, cross-system, and constantly up to date. We predict it’s the best high quality healthcare knowledge within the business. When researchers achieve entry to that depth of proof, they will examine affected person populations in ways in which claims knowledge and single-system EHR merely can’t help

What elements about what you are promoting led your traders to jot down the test?

Our traders acknowledged that Novellia is fixing a longstanding problem in pharmaceutical analysis, one of many largest and most economically steady industries on the planet: the business’s reliance on knowledge that’s usually fragmented, outdated, and disconnected from the affected person expertise. However what actually stood out was that we approached the issue from a essentially completely different angle. Slightly than constructing one other knowledge aggregation platform that operates behind the scenes, we began with the affected person, making a richer, extra longitudinal dataset for analysis. It’s an extremely troublesome factor to do properly, however when it begins to click on into place, there actually isn’t every other knowledge supply that may match its depth and high quality.

Our traders acknowledged that Novellia is fixing a longstanding problem in pharmaceutical analysis, one of many largest and most economically steady industries on the planet: the business’s reliance on knowledge that’s usually fragmented, outdated, and disconnected from the affected person expertise. However what actually stood out was that we approached the issue from a essentially completely different angle. Slightly than constructing one other knowledge aggregation platform that operates behind the scenes, we began with the affected person, making a richer, extra longitudinal dataset for analysis. It’s an extremely troublesome factor to do properly, however when it begins to click on into place, there actually isn’t every other knowledge supply that may match its depth and high quality.

What are the milestones you propose to realize within the subsequent six months?

Over the subsequent six months, we are going to use the funding to additional scale Novellia’s expertise platform and speed up our go-to-market efforts. At the moment, our prospects embody a number of of the world’s largest pharmaceutical firms. This funding will enable us to deepen these relationships, attain new prospects, and proceed rising the platform to higher serve each sufferers and the life sciences business.

The affected person facet and the business facet transfer collectively. That’s the plan.

What recommendation are you able to provide firms in New York that don’t have a contemporary injection of capital within the financial institution?

If you happen to’re constructing a enterprise enterprise, go for the grand slam. Cease serious about what it takes to get on first or second base. Try to be serious about doing no matter it takes to hit a grand slam and don’t, for a second, envision any end result apart from you doing this. Cease worrying about placing out. Go for gold. Take actual dangers and do no matter it takes. You study quick when the stakes are actual. Shifting ahead at first is discovered is a part of what will get you someplace value going.

Steadiness honesty and sustaining a contagious, stratospheric imaginative and prescient/ambition together with your crew. The founders I’ve seen navigate exhausting stretches greatest are those who talk clearly and belief their individuals with the fact of the state of affairs. Honesty builds the sort of belief that holds a crew collectively when issues get troublesome. On the opposite facet, it is advisable get galactic while you’re speaking in regards to the mission – your crew ought to really feel of their bones that this work goes to vary the world! Your enthusiasm and uncooked conviction in your imaginative and prescient must be shared and felt by each single member of your crew.

And use the New York ecosystem. It’s extremely collaborative and extremely sincere. New Yorkers are frank and low/no-BS by nature. Heat introductions, peer founder communities, the focus of healthcare and life sciences firms right here. These relationships matter while you’re extending runway.

The place do you see the corporate going now over the close to time period?

The factor I preserve coming again to is what it means to be the connective tissue. Proper now, a affected person’s well being knowledge exists in dozens of disconnected locations: their heart specialist doesn’t know what their oncologist did, their insurer is working from claims, the biopharma firm constructing life-changing medicines for them is inferring from incomplete inhabitants averages. Everybody is working on a partial image.

The place Novellia goes is towards changing into the canonical supply of reality for a affected person’s well being, and by extension, the infrastructure that connects sufferers to each single stakeholder of their ecosystem: their care crew, their researchers, their insurers, the scientists growing the subsequent technology of therapies. Not a intermediary. The layer that makes all of these relationships work higher.

Close to time period, which means scaling the platform, deepening our life sciences partnerships, and persevering with to develop a affected person group that trusts us as companions of their healthcare journeys.

However the north star is greater: a world the place a affected person’s well being document isn’t one thing they should chase down and carry in a binder however reasonably one thing that flows, with their consent, to the individuals and establishments that want it to maintain them wholesome and push drugs ahead.

What’s your favourite spring vacation spot in and across the metropolis?

A couple of spots! My spouse and I really like a superb boogie, so any rooftop or backyard in Brooklyn on an exquisite spring day with nice tunes is a should. I additionally love working round Brooklyn with a superb podcast; Prospect Park and the BK waterfront are favourite spots. And since I’m embarrassingly mainstream, Bathhouse, which now occurs to have a location strolling distance from my flat.

NYC Tech Daily Email

You’re seconds away from signing up for the most popular listing in NYC Tech!

Enroll as we speak



Source link

18M 50B AlleyWatch Data Development Drug Fix heart Novellia Problem raises sitting
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Business Circle Team
Business Circle Team
  • Website

Related Posts

Using Data to Remove Recruiting Bottlenecks and Bias

June 18, 2026

Survive Your Startup’s First Few Inspections by Sidestepping These 5 Snags

June 17, 2026

Thought of the day from Stoic philosopher Marcus Aurelius: “Each of us lives only in the present, this brief moment; the rest is either a life that is past or is an uncertain future.”

June 16, 2026

In Startup Building and Backing: Our Fates are Intertwined

June 16, 2026
LATEST UPDATES

Stop Waiting for Rates to Drop—New Construction Investors Already Bought at 4%

June 18, 2026

Novellia Raises $18M to Fix the $50B Data Problem Sitting at the Heart of Drug Development – AlleyWatch

June 18, 2026

265. “We spend 179% of what we make. Are we screwed?”

June 18, 2026

Announcing the First Batch of Speakers for MozCon NYC 2026

June 18, 2026

Are You Loud Budgeting? How to Make Your Financial Goals Stick

June 18, 2026

The best power banks and battery packs in the UK for reliable charging on the go, tested | Technology

June 18, 2026

Subscribe to Updates

Get the latest sports news from SportsSite about soccer, football and tennis.

Business, Finance and Market Growth News Site

Important Pages
  • Advertise with us
  • Submit Articles
  • About us
  • Contact us
Recent Posts
  • Stop Waiting for Rates to Drop—New Construction Investors Already Bought at 4%
  • Novellia Raises $18M to Fix the $50B Data Problem Sitting at the Heart of Drug Development – AlleyWatch
  • 265. “We spend 179% of what we make. Are we screwed?”
© 2026 BusinessCircle.co
  • Privacy Policy
  • Terms and Conditions
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA

Type above and press Enter to search. Press Esc to cancel.